Studies

All studies in your compliance portfolio

Study	Sponsor	Phase	Indication	Readiness	Grade	Status
Phase III BEACON-CML STUDY-001	Gilead Sciences	Phase III	CML	92	A	Active
Phase II NOVA-AML STUDY-002	Bristol Myers Squibb	Phase II	AML	78	C	Active
Phase I HORIZON-MDS STUDY-003	Novartis	Phase I	MDS	65	D	Active
Phase III APEX-ALL STUDY-004	Amgen	Phase III	ALL	88	B	Active
Phase II STELLAR-MM STUDY-005	Johnson & Johnson	Phase II	MM	45	F	At Risk